IMNM
Immunome Inc.
+0.70 (+3.01%)24.17USD263K成交股數2.7B市值–本益比(近四季)–股價營收比-100.0%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 18 · 14.9M · 4 |
| 其中 10b5-1 計畫賣出 | 18 筆 |
| 近 180 天 買進 · 賣出金額 | 808K · 17.8M |
| 近 180 天 淨額 | −17.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | 09-15 | Higgins Jack | Chief Scientific Officer | M 選擇權執行 | 18.0K | 1.35 | 24K | 78.3K | SEC |
| 2026-09-11 | 09-15 | Higgins Jack | Chief Scientific Officer | G 贈與 | 8.8K | – | – | 56.3K | SEC |
| 2026-09-11 | 09-15 | Higgins Jack | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 13.2K | 25.32 | 334K | 65.0K | SEC |
| 2026-08-12 | 08-12 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 11.0K | 27.25 | 301K | 92.2K | SEC |
| 2026-08-11 | 08-12 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 62.3K | 26.23 | 1.6M | 0 | SEC |
| 2026-08-10 | 08-12 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 10.1K | 26.07 | 264K | 62.3K | SEC |
| 2026-08-07 | 08-10 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 15.2K | 26.06 | 397K | 72.4K | SEC |
| 2026-08-06 | 08-10 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 20.8K | 26.06 | 543K | 87.7K | SEC |
| 2026-08-04 | 08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | M 選擇權執行 | 50.4K | 12.92 | 651K | 50.4K | SEC |
| 2026-08-04 | 08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | M 選擇權執行 | 40.3K | 10.60 | 427K | 90.6K | SEC |
| 2026-08-04 | 08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | S 公開市場賣出(10b5-1) | 90.6K | 25.09 | 2.3M | 0 | SEC |
| 2026-07-23 | 07-27 | Lechleider Robert | Chief Medical Officer | A 獲配股票 | 54.0K | – | – | 69.8K | SEC |
| 2026-07-23 | 07-27 | Higgins Jack | Chief Scientific Officer | A 獲配股票 | 38.3K | – | – | 60.3K | SEC |
| 2026-07-23 | 07-27 | Horn Kinney | CHIEF BUSINESS OFFICER | A 獲配股票 | 31.3K | – | – | 31.3K | SEC |
| 2026-07-23 | 07-27 | Rosett Max | Chief Financial Officer | A 獲配股票 | 47.3K | – | – | 101K | SEC |
| 2026-07-23 | 07-27 | SIEGALL CLAY B | President and CEO | A 獲配股票 | 180K | – | – | 871K | SEC |
| 2026-07-23 | 07-27 | Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A 獲配股票 | 38.3K | – | – | 43.8K | SEC |
| 2026-07-23 | 07-27 | Tsai Philip | Chief Technical Officer | A 獲配股票 | 38.3K | – | – | 81.5K | SEC |
| 2026-07-07 | 07-09 | Horn Kinney | CHIEF BUSINESS OFFICER | S 公開市場賣出(10b5-1) | 1.1K | 25.00 | 27K | 0 | SEC |
| 2026-07-07 | 07-09 | Horn Kinney | CHIEF BUSINESS OFFICER | M 選擇權執行 | 1.1K | 12.92 | 14K | 1.1K | SEC |
| 2026-07-07 | 07-07 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 16.9K | 24.20 | 409K | 109K | SEC |
| 2026-07-06 | 07-07 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 83.1K | 24.11 | 2.0M | 125K | SEC |
| 2026-07-02 | 07-07 | Lechleider Robert | Chief Medical Officer | S 公開市場賣出(10b5-1) | 16.1K | 23.44 | 377K | 15.8K | SEC |
| 2026-07-02 | 07-07 | Lechleider Robert | Chief Medical Officer | M 選擇權執行 | 55.0K | 8.73 | 480K | 70.8K | SEC |
| 2026-07-02 | 07-07 | Lechleider Robert | Chief Medical Officer | S 公開市場賣出(10b5-1) | 22.7K | 21.95 | 499K | 48.1K | SEC |
| 2026-07-02 | 07-07 | Lechleider Robert | Chief Medical Officer | S 公開市場賣出(10b5-1) | 16.2K | 22.76 | 369K | 31.9K | SEC |
| 2026-07-02 | 07-02 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 75.7K | 22.35 | 1.7M | 233K | SEC |
| 2026-07-02 | 07-02 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 24.3K | 23.33 | 568K | 209K | SEC |
| 2026-06-30 | 07-02 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 101K | 21.12 | 2.1M | 309K | SEC |
| 2026-06-25 | 06-29 | Lechleider Robert | Chief Medical Officer | M 選擇權執行 | 55.0K | 8.73 | 480K | 70.8K | SEC |
| 2026-06-25 | 06-29 | Lechleider Robert | Chief Medical Officer | S 公開市場賣出(10b5-1) | 40.6K | 19.56 | 794K | 30.2K | SEC |
| 2026-06-25 | 06-29 | Lechleider Robert | Chief Medical Officer | S 公開市場賣出(10b5-1) | 14.4K | 20.66 | 298K | 15.8K | SEC |
| 2026-06-15 | 06-17 | Rosett Max | Chief Financial Officer | M 選擇權執行 | 60.0K | 1.05 | 63K | 114K | SEC |
| 2026-06-15 | 06-17 | Rosett Max | Chief Financial Officer | S 公開市場賣出(10b5-1) | 60.0K | 18.23 | 1.1M | 54.0K | SEC |
| 2026-06-05 | 06-09 | BIENAIME JEAN JACQUES | Director | S 公開市場賣出 | 500 | 19.44 | 10K | 42.9K | SEC |
| 2026-06-05 | 06-09 | BIENAIME JEAN JACQUES | Director | S 公開市場賣出 | 10.0K | 19.41 | 194K | 32.9K | SEC |
| 2026-06-05 | 06-09 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 6.0K | 19.48 | 117K | 38.9K | SEC |
| 2026-06-05 | 06-09 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 3.5K | 19.46 | 68K | 42.4K | SEC |
| 2026-06-05 | 06-09 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 19.27 | 19K | 43.4K | SEC |
| 2026-05-15 | 05-19 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 5.0K | 20.70 | 104K | 43.4K | SEC |
| 2026-04-02 | 04-03 | Rosett Max | Chief Financial Officer | M 選擇權執行 | 31.8K | 1.05 | 33K | 79.3K | SEC |
| 2026-04-02 | 04-03 | Higgins Jack | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 9.4K | 21.64 | 204K | 22.0K | SEC |
| 2026-04-02 | 04-03 | Rosett Max | Chief Financial Officer | M 選擇權執行 | 39.7K | 1.35 | 54K | 119K | SEC |
| 2026-04-02 | 04-03 | Rosett Max | Chief Financial Officer | S 公開市場賣出(10b5-1) | 63.7K | 21.91 | 1.4M | 55.4K | SEC |
| 2026-04-02 | 04-03 | Rosett Max | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.3K | 22.48 | 30K | 54.0K | SEC |
| 2026-03-30 | 04-01 | Higgins Jack | Chief Scientific Officer | G 贈與 | 6.3K | – | – | 31.4K | SEC |
| 2026-03-27 | 03-31 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 25.4K | 19.67 | 501K | 691K | SEC |
| 2026-03-23 | 03-23 | WAGENHEIM PHILIP | Director | S 公開市場賣出 | 28.2K | 20.65 | 582K | 341K | SEC |
| 2026-03-20 | 03-23 | WAGENHEIM PHILIP | Director | S 公開市場賣出 | 36.8K | 20.47 | 753K | 369K | SEC |
| 2026-03-11 | 03-12 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 21.55 | 22K | 38.4K | SEC |
| 2026-03-10 | 03-12 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 1.0K | 22.12 | 22K | 37.4K | SEC |
| 2025-12-30 | 12-30 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 4.7K | 21.15 | 100K | 665K | SEC |
| 2025-12-22 | 12-23 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 372K | 21.72 | 8.1M | 2.0M | SEC |
| 2025-12-22 | 12-23 | Barchas Isaac | Director | S 公開市場賣出(10b5-1) | 11.3K | 22.34 | 251K | 2.0M | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 1.0K | SEC |
| 2025-12-19 | 12-22 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 7.3K | 20.48 | 149K | 861K | SEC |
| 2025-12-19 | 12-22 | SIEGALL CLAY B | President and CEO | G 贈與 | 200K | – | – | 661K | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 39.7K | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 38.7K | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 1.0K | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 37.7K | SEC |
| 2025-12-19 | 12-22 | Higgins Jack | Chief Scientific Officer | G 贈與 | 1.0K | – | – | 1.0K | SEC |
| 2025-12-19 | 12-22 | Tsai Philip | Chief Technical Officer | P 公開市場買進 | 10.0K | 20.49 | 205K | 43.3K | SEC |
| 2025-12-18 | 12-18 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 46.5K | 21.50 | 1,000K | 853K | SEC |
| 2025-09-10 | 09-11 | Higgins Jack | Chief Scientific Officer | M 選擇權執行 | 22.0K | 1.35 | 30K | 40.7K | SEC |
| 2025-06-03 | 06-03 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 5.0K | 9.38 | 47K | 36.4K | SEC |
| 2025-03-27 | 03-28 | Higgins Jack | Chief Scientific Officer | M 選擇權執行 | 5.2K | 1.35 | 7K | 18.7K | SEC |
| 2025-03-26 | 03-26 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 137K | 7.29 | 999K | 807K | SEC |
| 2025-03-25 | 03-26 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 7.8K | 7.78 | 61K | 31.4K | SEC |
| 2025-03-24 | 03-25 | Tsai Philip | Chief Technology Officer | P 公開市場買進 | 12.3K | 8.42 | 104K | 33.3K | SEC |
| 2025-03-24 | 03-25 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 7.0K | 8.21 | 57K | 23.6K | SEC |
| 2025-01-31 | 02-03 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 150K | 7.75 | 1.2M | 670K | SEC |
| 2024-11-22 | 11-25 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 33.9K | 9.78 | 332K | 520K | SEC |
| 2024-11-21 | 11-25 | Tsai Philip | Chief Technology Officer | P 公開市場買進 | 21.0K | 9.43 | 198K | 21.0K | SEC |
| 2024-11-21 | 11-25 | Lechleider Robert | Chief Medical Officer | P 公開市場買進 | 15.8K | 9.48 | 150K | 15.8K | SEC |
| 2024-11-21 | 11-25 | SIEGALL CLAY B | President and CEO | P 公開市場買進 | 66.1K | 9.54 | 630K | 486K | SEC |
| 2024-09-19 | 09-20 | Rosett Max | Chief Financial Officer | M 選擇權執行 | 42.0K | 1.05 | 44K | 61.9K | SEC |
| 2024-09-19 | 09-20 | Rosett Max | Chief Financial Officer | S 公開市場賣出 | 14.4K | 16.01 | 230K | 47.5K | SEC |
| 2024-08-19 | 08-19 | Higgins Jack | Chief Scientific Officer | G 贈與 | 2.5K | – | – | 13.5K | SEC |
| 2024-08-16 | 08-19 | BIENAIME JEAN JACQUES | Director | P 公開市場買進 | 7.0K | 13.94 | 98K | 16.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 17.0M | 360M | 新進 | 新進 |
| BlackRock, Inc. | 8.8M | 187M | 新進 | 新進 |
| STATE STREET CORP | 5.5M | 116M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.2M | 110M | 新進 | 新進 |
| Redmile Group, LLC | 4.9M | 104M | 新進 | 新進 |
| PRIMECAP MANAGEMENT CO/CA/ | 4.6M | 97.1M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | 96.4M | 新進 | 新進 |
| Driehaus Capital Management LLC | 4.3M | 92.1M | 新進 | 新進 |
| ENAVATE SCIENCES GP, LLC | 3.6M | 76.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | 58.4M | 新進 | 新進 |
| MORGAN STANLEY | 2.4M | 51.0M | 新進 | 新進 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.0M | 42.7M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.8M | 39.0M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 1.7M | 36.5M | 新進 | 新進 |
| READYSTATE ASSET MANAGEMENT LP | 1.6M | 34.0M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.5M | 32.0M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | 28.6M | 新進 | 新進 |
| PRINCIPAL FINANCIAL GROUP INC | 1.3M | 28.6M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | 26.5M | 新進 | 新進 |
| Woodline Partners LP | 1.0M | 21.2M | 新進 | 新進 |
| NORTHERN TRUST CORP | 968K | 20.5M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886K | 18.8M | 新進 | 新進 |
| MetLife Investment Management, LLC | 859K | 18.2M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 756K | 16.0M | 新進 | 新進 |
| Pivotal bioVenture Partners Investment Advisor LLC | 733K | 15.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 202 +0 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 202 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 118M · 100.0% |
| 合計季末市值 | 2.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 15.6M |
|---|---|
| 與上期比 | -10.1% |
| 佔流通股數 | 13.77% |
| 日均成交量 | 1.2M |
| 回補天數 | 12.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 15.6M | -10.1% | 13.77% | 1.2M | 12.6 |
| 2026-08-14 | 17.4M | -3.3% | 15.31% | 1.2M | 14.9 |
| 2026-07-31 | 18.0M | +4.3% | 15.83% | 783K | 23.0 |
| 2026-07-15 | 17.2M | -0.7% | 15.18% | 1.6M | 10.5 |
| 2026-06-30 | 17.4M | -4.3% | 15.29% | 2.1M | 8.1 |
| 2026-06-15 | 18.1M | +7.6% | 15.98% | 1.4M | 12.9 |
| 2026-05-29 | 16.9M | -4.3% | 14.85% | 1.2M | 14.2 |
| 2026-05-15 | 17.6M | -5.5% | 15.52% | 879K | 20.1 |
| 2026-04-30 | 18.7M | +0.3% | 16.43% | 824K | 22.6 |
| 2026-04-15 | 18.6M | -1.8% | 16.38% | 1.1M | 16.6 |
| 2026-03-31 | 18.9M | +5.9% | 16.68% | 1.8M | 10.6 |
| 2026-03-13 | 17.9M | -0.0% | 15.75% | 1.2M | 14.7 |
| 2026-02-27 | 17.9M | +11.5% | 15.75% | 757K | 23.6 |
| 2026-02-13 | 16.0M | +1.7% | 14.13% | 1.3M | 12.3 |
| 2026-01-30 | 15.8M | +3.0% | 13.88% | 1.7M | 9.1 |
| 2026-01-15 | 15.3M | -12.7% | 13.48% | 2.5M | 6.3 |
| 2025-12-31 | 17.5M | +10.4% | 15.44% | 3.4M | 5.1 |
| 2025-12-15 | 15.9M | +4.0% | 13.98% | 2.2M | 7.4 |
| 2025-11-28 | 15.3M | +6.6% | 13.44% | 1.1M | 14.4 |
| 2025-11-14 | 14.3M | -5.1% | 12.61% | 1.7M | 8.4 |
| 2025-10-31 | 15.1M | -0.9% | 13.29% | 1.0M | 14.6 |
| 2025-10-15 | 15.2M | -1.5% | 13.42% | 1.5M | 10.1 |
| 2025-09-30 | 15.5M | +3.3% | 13.62% | 2.1M | 7.4 |
| 2025-09-15 | 15.0M | +10.4% | 13.18% | 1.5M | 10.1 |
| 2025-08-29 | 13.6M | -1.4% | 11.94% | 618K | 21.9 |
| 2025-08-15 | 13.8M | -3.2% | 12.12% | 665K | 20.7 |